[HTML][HTML] Harnessing real-world data to inform decision-making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

…, X Montalban, RT Naismith, JA Nicholas… - Frontiers in …, 2020 - frontiersin.org
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS
PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper …

Examining trait mindfulness, emotion dysregulation, and quality of life in multiple sclerosis.

B Schirda, JA Nicholas, RS Prakash - Health Psychology, 2015 - psycnet.apa.org
Objective: Dispositional mindfulness exhibits a positive association with quality of life (QoL).
One potential mechanism for this association is enhanced emotion regulation abilities. …

[HTML][HTML] Real-world adherence to, and persistence with, once-and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and …

JA Nicholas, NC Edwards, RA Edwards, A Dellarole… - BMC neurology, 2020 - Springer
Background Nonadherence to disease-modifying drugs (DMDs) for multiple sclerosis (MS)
is associated with poorer clinical outcomes, including higher rates of relapse and disease …

Male literacy," deskilling," and the Industrial Revolution

SJ Nicholas, JM Nicholas - The Journal of Interdisciplinary History, 1992 - JSTOR
Revolution Man does not live by bread alone, and how successfully societies provide for the
economic well-being of their populations is measured not only by real wages and per capita …

Associations of sNfL with clinico‐radiological measures in a large MS population

…, M Qiao, LB Krupp, JA Nicholas… - Annals of Clinical …, 2023 - Wiley Online Library
Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐throughput
assays on widely accessible platforms in large, real‐world MS populations, is a critical …

[HTML][HTML] Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data

JA Nicholas, B Electricwala, LK Lee, KM Johnson - BMC neurology, 2019 - Springer
Background Multiple sclerosis (MS) is prevalent among working age individuals (20–60
years), leading to high burden on work productivity. Few data are available about the …

Effects of 4-week mindfulness training versus adaptive cognitive training on processing speed and working memory in multiple sclerosis.

HR Manglani, S Samimy, B Schirda, JA Nicholas… - …, 2020 - psycnet.apa.org
Objective: The aim of this preregistered, secondary analysis of a pilot randomized controlled
trial (NCT02717429) was to compare the impact of 4-week mindfulness-based training and …

Balancing potential benefits and risks of Bruton Tyrosine Kinase inhibitor therapies in multiple sclerosis during the COVID-19 pandemic

MS Weber, JA Nicholas, MR Yeaman - Neurology …, 2021 - AAN Enterprises
Bruton tyrosine kinase inhibitors (BTKis) encompass a new class of therapeutics currently
being evaluated for the treatment of multiple sclerosis (MS). Whether BTKis affect COVID-19 …

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate

JA Nicholas, AL Boster, J Imitola… - Drug design …, 2014 - Taylor & Francis
Dimethyl fumarate (DMF) is the most recent oral disease-modifying therapy approved by the
US Food and Drug Administration and is indicated for the treatment of relapsing forms of …

A promising cognitive screener in multiple sclerosis: The NIH toolbox cognition battery concords with gold standard neuropsychological measures

…, ME Fisher, EJ Duraney, JA Nicholas… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: Routine cognitive screening is a priority in MS clinical care. The National
Institutes of Health Toolbox (NIHTB) Cognition Battery is a 30-min instrument validated in …